Daiichi Sankyo in UK
Working with the National Health Service (NHS)
At Daiichi Sankyo UK, the National Health Service is our biggest stakeholder. That’s why we make it our business to understand the challenges faced by the four devolved nations. Variations in policy and funding are often determined by disease morbidity and mortality rates. In the south of England, for example, deaths arising from CVD are lower than in other UK regions*.
Regional guidance from the National Institute for Health and Clinical Excellence (NICE), the Scottish Medicines Consortium and Scottish Intercollegiate Guidelines Network, and the All Wales Strategy Group has significant influence on prescribing and patient care.
Whilst we adapt our programmes to reflect the wider goals of the NHS, such as reducing the impact of CVD and diabetes**, we also tailor our service to meet the local needs of our customers. This collaborative approach between the NHS and industry, supported by the Department of Health and the ABPI***, enables pioneering treatments and models of care to be developed and delivered direct to patients.
* Scarborough P, Allender S, Peto V, and Rayner M (2008). Regional and social differences in Coronary Heart Disease 2008. British Heart Foundation: London
** CVD causes 208,000 deaths annually* and diabetes accounts for 5 per cent of NHS expenditure
*** Best practice guidelines for joint working between the NHS and the pharmaceutical industry. Department of Health , February 2008
Our customer focus
To meet the needs of the evolving NHS, commercial operations at Daiichi Sankyo UK are structured into regional business units. We maintain our competitive edge by deploying our people and resources appropriately across the country, according to local or individual requirements.
We work with prescribing advisors, GPs, nurses, dispensing managers, practice managers and retail chemists in primary care – through to consultants, hospital doctors, nurses, business managers and pharmacists in secondary care.
With such a diverse range of customers, we train our people to the highest level to provide quality advice and information on all our products.
Highly-skilled medical liaison and medical services teams complement our sales and marketing specialists by providing essential clinical, scientific, pharmacovigilance and regulatory support to our UK customers.
Great place to Work
We are one of the top 20 workplaces in the UK!
Daiichi Sankyo UK is an aspirational company with a strong desire to take on and beat the best in the pharmaceutical industry.
Daiichi Sankyo UK is one of the best companies to work for in the country. We have entered the Financial Times Great Place To Work survey since 2007 when we were ranked 36th. We are very proud to have climbed the rankings each year, and in 2010 we were placed 20th. We will continue to enter the survey every year to help us understand how we can continue to improve what we do.